While common sense may suggest that antibodies that do not neutralize the SARS-CoV-2 virus are of little value, recent studies show they can still confer protection against infection.
Are We Leaving Useful Antibodies Behind? The Value Of Non-Neutralizing Protective Monoclonal Antibodies
